Results 31 to 40 of about 22,304 (253)

Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study

BMJ Open, 2019
Objectives To assess whether changes in patterns of combined oral contraceptive (COC) prescriptions to starters between 2008 and 2016 were in line with changes in national recommendations for use.Design Historical prospective cohort study.Setting The ...
Julie Ekman, Finn Egil Skjeldestad
doaj   +1 more source

Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route

European journal of contraception & reproductive health care, 2020
Objective To compare systemic exposure to levonorgestrel (LNG) released from commercially available intrauterine systems (IUSs), a subdermal implant, and oral contraceptives.
B. Hofmann, D. Apter, J. Bitzer, Isabel Reinecke, M. Serrani, J. Höchel, Martin Merz   +6 more
semanticscholar   +1 more source

Breast Cancer Risk with Progestin Subdermal Implants: A Challenge in Patients Counseling

Frontiers in Endocrinology, 2021
There is a steady global rise in the use of progestin subdermal implants, where use has increased by more than 20 times in the past two decades. BC risk has been reported with the older progestin only methods such as oral pills, injectables, and ...
Ghada Mohammed, Noha A. Mousa, Iman M. Talaat, Iman M. Talaat, Haya Ibrahim, Maha Saber-Ayad, Maha Saber-Ayad   +6 more
doaj   +1 more source

Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users

Obstetrics and Gynecology, 2020
Copper intrauterine device users have a lower risk of high-grade cervical neoplasms compared with levonorgestrel-releasing intrauterine system users.
M. Spotnitz, K. Natarajan, P. B. Ryan, C. Westhoff   +3 more
semanticscholar   +1 more source

A Physiologically-Based Pharmacokinetic Simulation to Evaluate Approaches to Mitigate Efavirenz-Induced Decrease in Levonorgestrel Exposure with a Contraceptive Implant

Pharmaceutics
Background: Levonorgestrel implant is a highly effective hormonal contraceptive, but its efficacy may be compromised when used with cytochrome enzyme inducers such as efavirenz. The primary aim of this study was to evaluate methods of mitigating the drug
Lilian W. Adeojo, Rena C. Patel, Nancy C. Sambol   +2 more
doaj   +1 more source

Changes of Body Mass Index and Lipid Profile in Injectable Depot Medroxyprogesterone Acetate and Levonorgestrel Implant Acceptors

Indonesian Journal of Obstetrics and Gynecology, 2014
Objective: To determine the comparison of body mass index (BMI) among acceptors of injectable depot medroxyprogesterone acetate (DMPA) with levonorgestrel implant acceptors for 1 year and comparison of lipid profiles between depot medroxyprogesterone ...
Irwan Daido, Andi M Tahir, St Maisuri T Chalid   +2 more
doaj   +1 more source

COMPARATIVE ANALYSIS OF REQUIREMENTS FOR QUALITY CONTROL OF ETHINYL ESTRADIOL AND LEVONORGESTREL CONTAINING MEDICINAL PRODUCTS

Регуляторные исследования и экспертиза лекарственных средств, 2018
The article compares test methods and levels of requirements laid out in the world’s leading pharmacopoeias and in manufacturers’ specifications with regard to the quality of levonorgestrel and ethinyl estradiol containing medicinal products used as oral
V. I. Seredenko, A. V. Korolev, L. G. Maslov, T. Yu. Belova, N. N. Dolgushina   +4 more
doaj   +1 more source

Efficacy of cyclic and extended regimens of ethinylestradiol 0.02 mg ‐levonorgestrel 0.09 mg for dysmenorrhea: A placebo‐controlled, double‐blind, randomized trial

Reproductive Medicine and Biology, 2021
Purpose We aimed to evaluate the efficacy and safety of 28‐day Cyclic and 84‐day Extended regimens of NPC‐16 (ethinylestradiol 0.02 mg plus levonorgestrel 0.09 mg) in patients with dysmenorrhea.
Tasuku Harada, Mikio Momoeda
doaj   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, EarlyView.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source

Development and Pilot Testing of a Dispensing Protocol on Emergency Contraceptive Pills for Community Pharmacists in Belgium

Pharmacy, 2022
Community pharmacists in Belgium frequently dispense emergency contraceptive pills (ECPs). However, variable and insufficient counseling practices exist across pharmacies, highlighting the need for standardization and quality improvement strategies.
Michael Ceulemans, Marieke Brughmans, Laura-Lien Poortmans, Ellen Spreuwers, Julie Willekens, Nele Roose, Isabelle De Wulf, Veerle Foulon   +7 more
doaj   +1 more source